Zeronda Tyler 4
4 · VYNE Therapeutics Inc. · Filed Oct 4, 2023
Insider Transaction Report
Form 4
Zeronda Tyler
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2023-10-02$3.83/sh−1,087$4,163→ 6,930 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.